This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Tel Aviv University. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Adva Krivitsky: Innovator in Oligonucleotide Delivery
Introduction
Adva Krivitsky is a notable inventor based in Bnei-Zion, Israel. He has made significant contributions to the field of biotechnology, particularly in the area of oligonucleotide delivery systems. His innovative work has the potential to impact various applications in medicine and genetic research.
Latest Patents
Adva holds a patent for "Polyaminated Polyglutamic Acid-Containing Compounds and Uses Thereof for Delivering Oligonucleotides." This patent highlights his focus on developing advanced methods for delivering therapeutic oligonucleotides, which are crucial for gene therapy and other medical applications. He has 1 patent to his name, showcasing his commitment to innovation in this specialized field.
Career Highlights
Adva is affiliated with Tel Aviv University, where he engages in cutting-edge research and development. His work at the university allows him to collaborate with other experts in the field and contribute to the advancement of biotechnology. His research has garnered attention for its potential to revolutionize how oligonucleotides are delivered in therapeutic settings.
Collaborations
Adva collaborates with talented colleagues, including Anna Scomparin and Dina Polyak. These partnerships enhance the research environment and foster innovation, leading to new discoveries and advancements in their shared field of study.
Conclusion
Adva Krivitsky is a pioneering inventor whose work in oligonucleotide delivery systems is paving the way for future advancements in biotechnology. His contributions are significant, and his collaborations with esteemed colleagues further enhance the impact of his research.